ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,000 | -60.0% | 3,517 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -54.5% | 3,517 | 0.0% | 0.00% | – |
Q3 2016 | $11,000 | 0.0% | 3,517 | 0.0% | 0.00% | – |
Q2 2016 | $11,000 | -15.4% | 3,517 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | +30.0% | 3,517 | +63.8% | 0.00% | – |
Q4 2015 | $10,000 | – | 2,147 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 861,723 | $1,174,000 | 0.98% |
R&F Capital Advisors LP | 171,205 | $111,000 | 0.04% |
Rhenman & Partners Asset Management AB | 200,000 | $130,000 | 0.02% |
Rock Springs Capital Management LP | 380,000 | $247,000 | 0.02% |
WHITE PINE CAPITAL LLC | 35,000 | $23,000 | 0.01% |
BVF INC/IL | 62,292 | $40,000 | 0.01% |
Virtu KCG Holdings LLC | 271,239 | $176,000 | 0.00% |
TURNER INVESTMENTS LLC | 15,000 | $10,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,736 | $8,000 | 0.00% |
Tower Research Capital LLC (TRC) | 36,413 | $24,000 | 0.00% |